Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications

Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications

Objective: Small cell prostate carcinoma (SCPC) is a rare and highly malignant subtype of prostate cancer. SCPC frequently lacks androgen receptor (AR) and prostate-specific antigen (PSA) expression, and often responds poorly to androgen deprivation therapy (ADT). AR splice variant-7 (AR-V7) is a tr...

Full description

Bibliographic Details
Main Authors:	Pei Zhao, Yezi Zhu, Liang Cheng, Jun Luo
Format:	Article
Language:	English
Published:	Elsevier 2019-01-01
Series:	Asian Journal of Urology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388218300754

Similar Items

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
by: Ramesh Narayanan
Published: (2020-07-01)

Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01)

The evolution of prostate cancer therapy: targeting the androgen receptor (AR)
by: Jeanny B. Aragon-Ching
Published: (2014-10-01)

Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells.
by: Wolfgang Streicher, et al.
Published: (2014-01-01)

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
by: Carlo Cattrini, et al.
Published: (2019-09-01)

Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
by: Manjul Rana, et al.
Published: (2021-01-01)

Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients
by: Paul König, et al.
Published: (2020-09-01)

Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies
by: Yafeng Ma, et al.
Published: (2016-08-01)

Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
by: Young-Chae Kim, et al.
Published: (2015-01-01)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
by: Masahiro Sugiura, et al.
Published: (2021-01-01)

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
by: Vincenza Conteduca, et al.
Published: (2020-06-01)

Expression of AR-V7 in urine-derived exosomal RNA and resistance to androgen deprivation therapy in prostate cancer
by: J.Y. Ku, et al.
Published: (2020-07-01)

Author Correction: Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
by: Manjul Rana, et al.
Published: (2021-05-01)

Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: A systematic review and meta‐analysis
by: Qinchen Li, et al.
Published: (2021-09-01)

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
by: Namrata Khurana, et al.
Published: (2020-01-01)

Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy
by: Vincent Wing Sun Liu, et al.
Published: (2017-05-01)

Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer
by: Yukiyoshi Hirayama, et al.
Published: (2020-10-01)

SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer
by: Mao Ding, et al.
Published: (2020-02-01)

Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
by: Neetu Saxena, et al.
Published: (2021-05-01)

Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells.
by: Congcong Chen, et al.
Published: (2016-01-01)

Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward activate its own gene expression through AR protein stability
by: Pei-Hong Chen, et al.
Published: (2008)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
by: Sushant V Chavan, et al.
Published: (2014-01-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway
by: Zhengfang Liu, et al.
Published: (2021-02-01)

The Role of Androgen Receptor (AR) and Estrogen Receptor (ER) in Androgen Facilitation of Follicle-Stimulating Hormone (FSH)-Induced Steroidogenesis
by: Hui-Ling Chen, et al.
Published: (2011)

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
by: Giuseppe Bronte, et al.
Published: (2019-01-01)

Correction: Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells.
by: Congcong Chen, et al.
Published: (2019-01-01)

The Effect of Androgen and Androgen Receptor（AR）Signaling on the Adipogenic Differentiation of D1 Mesenchymal Multipotent Progenitor Cells
by: Jyun-Ya Wang, et al.
Published: (2010)

The Effect of Androgen and Androgen Receptor (AR) Signaling on The Osteogenic Differentiation of D1 Mesenchymal Multipotent Progenitor Cells
by: Yi-Chen Liou, et al.
Published: (2010)

Androgen receptor (AR) physiological roles in individualtestis cells and ovarian granulosa cells
by: Ruey-Sheng Wang, et al.
Published: (2014)

Identification of Androgen Receptor Associated Proteins Related with HBV Enhanced AR Activity
by: Ya-Wen Cheng, et al.
Published: (2008)

Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog—Thalidomide PROTACs
by: Ga-Yeong Kim, et al.
Published: (2021-04-01)

Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer
by: XinTao Gao, et al.
Published: (2021-07-01)

The Role of Fibroblast Growth Factor Receptor 3 (FGFR3) and Androgen Receptor (AR) in a Non-invasive Urothelial Carcinoma Recurrences
by: Oki Meilani Dewi, et al.
Published: (2019-08-01)

Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progressionResearch in context
by: Fu-Ju Chou, et al.
Published: (2019-02-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

Methylation and Androgen Receptor Gene Expression in Prostate
by: Pei-I Lin, et al.
Published: (2004)

An influence of androgen receptor (AR) gene СAG-polymorphism on spermatogenesis in infertile men
by: V. B. Chernykh, et al.
Published: (2016-03-01)

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
by: Yuan Liu, et al.
Published: (2021-09-01)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption
by: Navid Sobhani, et al.
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_m7q8khkirgkbn1n6j8ica6eqep